Free shipping on all orders over $ 500

TH588

Cat. No. M8899

All AbMole products are for research use only, cannot be used for human consumption.

TH588 Structure
Size Price Availability Quantity
10mg USD 125  USD125 In stock
50mg USD 300  USD300 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

TH588 a first-in-class nudix hydrolase family inhibitor that potently and selectively engages and inhibits the MTH1 protein in cells. Protein co-crystal structures demonstrate that the inhibitor binds in the active site of MTH1.

MTH1 inhibitor TH588 is highly selective towards MTH1, with no relevant inhibition of other members of the nudix protein family or a panel of 87 enzymes, GPCRs, kinases, ion channels and transporter. TH588 also induces DNA damage and triggers an ATM-p53-mediated death response and DNA repair in U2OS cells. TH588 has been shown to selectively kill a variety of cancer cell lines and with in vivo activity shown for TH588 in SW480 colorectal and MCF7 breast tumour xenografts.

In mice bearing SW480 colorectal or MCF7 breast tumor xenografts, TH588 (30 mg/kg s.c.) reduces tumor growth via MTH1 inhibition. In mice carrying patient with BRAFV600E mutated xenografts, TH588 (30 mg/kg s.c.) also causes a reduced tumor growth rate.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models SCID mice bearing SW480 xenografts or MCF-7 xenografts; NOD-SCID IL2Rγnull (NOG) mice bearing patient with BRAFV600E mutated xenografts
Formulation 2% DMSO, 10% ethanol, 10% cremaphore, 10% Tween 80, 68% PBS; 10% N-methylpyrrilidone, 90% PEG300
Dosages 30 mg/kg, once daily
Administration s.c.
Chemical Information
Molecular Weight 295.17
Formula C13H12Cl2N4
CAS Number 1609960-31-7
Solubility (25°C) DMSO 18 mg/mL warmed
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Saleh A, et al. J Pharm Biomed Anal. Development and validation of method for TH588 and TH287, potent MTH1 inhibitors and new anti-cancer agents, for pharmacokinetic studies in mice plasma.

[2] Gad H, et al. Nature. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.

Related MTH1 Products
(S)-crizotinib

(S)-crizotinib, the (S)-enantiomer of crizotinib, is a potent MTH1 (NUDT1) inhibitor with IC50 of 72 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: TH588 supplier, MTH1, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.